Showing results (491-500 of 635) with videos related to

Sort By:
Pageof 64
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy QuestionnaireYasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
Journal of the American College of Cardiology|June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
European Journal of Heart Failure|July 17, 2024
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVERAmr Abdin, Toru Kondo, Michael Böhm, et al.
European Journal of Heart Failure|April 11, 2025
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
Circulation|September 1, 2024
Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical TrialsJawad H Butt, John J V McMurray, Brian L Claggett, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2026
Finerenone and eGFR slope across Different Levels of Baseline Albuminuria and Estimated Glomerular Filtration Rate: Insights from FINEARTS-HFFinnian R Mc Causland, Hiddo J L Heerspink, Muthiah Vaduganathan, et al.
Pageof 64